Slide 1: Q2 2026 Earnings Call
Q2 2026 Earnings Call JULY 28, 2026 1
Slide 2: Forward-looking statements
Forward-looking statements Safe Harbor Statement Statements included in this presentation that are not a description of historical facts are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 193
Slide 3: Non-GAAP and Additional Information
Non-GAAP and Additional Information Non-GAAP Information This presentation includes the following financial measures that are not presented in accordance with generally accepted accounting principles in the United States of America (“GAAP”): (1) Adjusted operating expenses, which the Company defines
Slide 4: Q2 2026 Summary
Q2 2026 Summary Revenue growth of 7% YoY reflecting improving demand and share gains Top-line Expansion Sales exceeded mid-point of guidance Profitability Strong YoY margin and earnings improvement (Adj. EPS $0.92, Adj. EBITDA 17.3%) Improvements Adjusted EPS in guidance range, but below mid-point d
Slide 5: Q2 2026 Sales By End Market
Q2 2026 Sales By End Market Market % of Sales 1 Comments versus Q2’25 results High single digit year-over-year growth from continued improvement in EMS Industrial2 37% general industrial sales in the U.S. and Europe and mass transit sales. Low single digit growth in automotive end market from improv
Slide 6: Save The Date – Investor Day
Save The Date – Investor Day Wednesday, September 30, 2026 Analyst & Key Focus Areas: Investor Day • Strategy update • Growth potential in data centers and other attractive end-markets • Capital allocation priorities • Longer-term financial plan 6
Slide 7: Financial Summary
Financial Summary (in millions, except for EPS) Q2’26 Q1’26 Q2’25 Net sales $216.8 $200.5 $202.8 Q2’26 Sales +7% YoY. $5.3M FX benefit. AES sales +7.8% YoY. Higher electronics & comms Gross margin % 32.5% 32.2% 31.6% and auto markets. $3.3M FX benefit. Net income (loss) $13.6 $4.5 $(73.6) EMS sales
Slide 8: Q2 2026 Adjusted EBITDA
Q2 2026 Adjusted EBITDA* $3.3 ($ in millions) $3.3 $3.0 $37.6 $5.1 $1.0 17.3% $23.9 11.8% 17.3% Q2'25 Volume / Mix New factory Operational Adjusted Other income Q2'26 performance excellence operating (expense) expenses 1 A d ju ste d EBITDA Im p ro vem ent D ri ve n By H i gh e r Vo l u m e A n d P
Slide 9: Q2 2026 Cash Utilization
Q2 2026 Cash Utilization $37.6 ($ in millions) $6.1 $7.9 $4.4 $3.0 $0.6 $195.8 $211.4 Mar 31, 2026 Adj. EBITDA 1 Capex Working capital Cash taxes Share Restructuring and Jun 30, 2026 Cash and change 2 paid repurchases other Cash and Short-Term Short-Term Investments Investments Bal an c e Sh e et Re
Slide 10: Q3 2026 Guidance
Q3 2026 Guidance Q3 2026 Net Sales $233M to $243M Sales midpoint of $238M increasing 10% YoY Gross Margin 33.2% to 34.2% Adjusted Earnings Per Diluted Share $1.10 to $1.30 Adj. EBITDA midpoint of $47M or 19.7% of Adjusted EBITDA $44M to $50M sales is improving 250 bps YoY 2026 Capital Expenditures $
Slide 11: Appendix
\ Appendix ROGERS CORPORATION, i
Slide 12: Historical Sales By End Market
Historical Sales By End Market First Half 2025 FY 2025 Market % o f Sales 1 % o f Sales 1 Industrial2 36% 36% Automotive3 27% 26% Electronics & Communications4 15% 16% Aerospace & Defense 16% 16% 1 – Percentages reflect year-to-date sales and are approximate. 2 – Includes general industrial, renewab
Slide 13: Q2 2026: Adjusted Operating Expenses Reconciliation
Q2 2026: Adjusted Operating Expenses Reconciliation* ($ in millions) Q2 2026 Q1 2026 Q2 2025 GAAP Operating Expenses $50.4 $53.9 $131.5 Intangible Amortization ($2.6) ($2.7) ($2.7) Restructuring, Severance, Impairment and Other Related Costs ($0.7) ($5.9) ($76.1) Total Adjustments ($3.3) ($8.6) ($78
Slide 14: Q2 2026: Adjusted Earnings Per Diluted Share Reconciliation
Q2 2026: Adjusted Earnings Per Diluted Share Reconciliation Q2 2026 Q1 2026 Q2 2025 GAAP Earnings (Loss) Per Diluted Share $0.76 $0.25 ($4.00) Intangible Amortization $0.14 $0.15 $0.15 Restructuring, Severance, Impairment and Other Related Costs $0.04 $0.33 $4.14 Valuation Allowance on Deferred Tax
Slide 15: Q2 2026: Adjusted EBITDA and Margin Reconciliation
Q2 2026: Adjusted EBITDA and Margin Reconciliation ($ in millions) Q2 2026 Q1 2026 Q2 2025 GAAP Net Income (Loss) $13.6 $4.5 ($73.6) Intangible Amortization $2.6 $2.7 $2.7 Restructuring, Severance, Impairment and Other Related Costs $0.7 $5.9 $76.1 Interest (Income) Expense, net ($0.3) ($0.3) ($0.4)
Slide 16: Q2 2026: Free Cash Flow Reconciliation
Q2 2026: Free Cash Flow Reconciliation ($ in millions) Q2 2026 Q1 2026 Q2 2025 Net Cash Provided By Operating Activities $24.4 $5.8 $13.7 Non-Acquisition Capital Expenditures ($6.1) ($4.7) ($8.1) Free Cash Flow $18.3 $1.1 $5.6 Note: dollars may not add due to rounding. 16 *Free cash flow defined as